Subscribe To

Price Alert Latest News Economic Calendar News

DH / Definitive Healthcare Corp. (DH) Q4 2022 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chairman Rick Booth - CFO Conference Call Participants David Grossman - Stifel Craig Hettenbach - Morgan Stanley Jacob Staffel - Goldman Sachs Matt Shea - Needham Ryan Shanahan - Canaccord Genuity Glen Santangelo - Jefferies Brian Peterson - Raymond James Anne Samuel - JPMorgan Allen Lutz - Bank of America Operator Ladies and gentlemen, greetings, and welcome to the Definitive Healthcare Fourth Quarter 2022 Earnings Conference Call. At this time, all participant lines are in a listen only mode. Read More

Demo Live Account See Partner Details

Content Topics

Definitive

Healthcare

Corp

DH

2022

Earnings

Call

Transcript

Stock

Posted: Feb 23 2023, 23:46

Author Name: Seeking Alpha

DH News

By Zacks Investment Research
October 20, 2023

Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?

Definitive Healthcare Corp. (DH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings

By Seeking Alpha
September 12, 2023

Definitive Healthcare: Fundamentals Remain Sound But Stock Sentiment Is Bad

DH Q2 results were solid, with revenue in line and adjusted EBITDA slightly ahead. The company's near-term outlook is uncertain due to macroeconomic f

By Seeking Alpha
August 14, 2023

Definitive Healthcare Corp. (DH) Q2 2023 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal O

By Zacks Investment Research
August 11, 2023

3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised

By Zacks Investment Research
August 10, 2023

Will Definitive Healthcare Corp. (DH) Beat Estimates Again in Its Next Earnings Report?

Definitive Healthcare Corp. (DH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients

By Seeking Alpha
June 14, 2023

Definitive Healthcare: Leading The Healthcare Commercial Intelligence Market

Definitive Healthcare Corp. is a leader in the healthcare commercial intelligence market, providing comprehensive data and insights for the industry w

By Seeking Alpha
May 6, 2023

Definitive Healthcare Corp. (DH) Q1 2023 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Of

By Zacks Investment Research
March 27, 2023

4 Toxic Stocks That You Should Eliminate From Your Portfolio

Similar to identifying stocks with growth potential, pinpointing toxic stocks and discarding them at the right time is the key to avoid losses. CSGP,

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.